Sitar Edward J
Insider CIK 1603489 · CGIX Chief Financial Officer · TMBR Director · INNT Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TMBR Timber Pharmaceuticals, In | A Award deriv | 2023-04-15 | 2023-04-18 | 5,327 | — | $0 | 5,327 | SEC↗ |
| TMBR Timber Pharmaceuticals, In | A Award | 2023-04-15 | 2023-04-18 | 5,327 | — | $0 | 11,127 | SEC↗ |
| TMBR Timber Pharmaceuticals, In | A Award | 2022-12-15 | 2022-12-16 | 2,500 | $1.63 | $4.1K | 5,800 | SEC↗ |
| TMBR Timber Pharmaceuticals, In | A Award deriv | 2022-04-15 | 2022-04-19 | 150,000 | — | $0 | 150,000 | SEC↗ |
| TMBR Timber Pharmaceuticals, In | A Award | 2022-04-15 | 2022-04-19 | 150,000 | — | $0 | 165,000 | SEC↗ |
| TMBR Timber Pharmaceuticals, In | P Buy | 2021-11-23 | 2021-11-24 | 15,000 | $0.46 | $6.9K | 15,000 | SEC↗ |
| NMTR 9 METERS BIOPHARMA, INC. | P Buy | 2021-09-14 | 2021-09-15 | 15,000 | $1.22 | $18.3K | 194,338 | SEC↗ |
| TMBR Timber Pharmaceuticals, In | A Award deriv | 2021-07-01 | 2021-07-06 | 47,623 | — | $0 | 47,623 | SEC↗ |
| NMTR 9 METERS BIOPHARMA, INC. | P Buy | 2021-04-05 | 2021-04-06 | 50,000 | $1.00 | $50.0K | 179,338 | SEC↗ |
| NMTR 9 METERS BIOPHARMA, INC. | A Award deriv | 2021-02-04 | 2021-02-05 | 477,468 | — | $0 | 477,468 | SEC↗ |
| NMTR 9 METERS BIOPHARMA, INC. | P Buy | 2020-12-15 | 2020-12-17 | 61,538 | $0.65 | $40.0K | 129,338 | SEC↗ |
| NMTR 9 METERS BIOPHARMA, INC. | A Award deriv | 2020-07-06 | 2020-07-08 | 225,000 | — | $0 | 775,000 | SEC↗ |
| NMTR 9 METERS BIOPHARMA, INC. | A Award deriv | 2020-07-06 | 2020-07-08 | 550,000 | — | $0 | 550,000 | SEC↗ |
| NMTR 9 METERS BIOPHARMA, INC. | C Conversion deriv | 2020-06-30 | 2020-07-02 | 678 | — | $0 | 0 | SEC↗ |
| NMTR 9 METERS BIOPHARMA, INC. | C Conversion | 2020-06-30 | 2020-07-02 | 67,800 | — | $0 | 67,800 | SEC↗ |
| TMBR Timber Pharmaceuticals, In | A Award deriv | 2020-06-08 | 2020-06-09 | 24,270 | — | $0 | 24,270 | SEC↗ |
| NMTR INNOVATE BIOPHARMACEUTICAL | P Buy deriv | 2020-05-04 | 2020-05-04 | 678 | — | $0 | 67,800 | SEC↗ |
| NMTR INNOVATE BIOPHARMACEUTICAL | P Buy deriv | 2020-05-04 | 2020-05-04 | 678 | — | $0 | 67,800 | SEC↗ |
| NMTR INNOVATE BIOPHARMACEUTICAL | A Award deriv | 2020-04-30 | 2020-05-04 | 125,000 | — | $0 | 125,000 | SEC↗ |
| NMTR INNOVATE BIOPHARMACEUTICAL | A Award deriv | 2020-04-24 | 2020-05-04 | 176,156 | — | $0 | 176,156 | SEC↗ |
| INNT INNOVATE BIOPHARMACEUTICAL | A Award deriv | 2019-07-01 | 2019-07-03 | 350,000 | — | $0 | 350,000 | SEC↗ |
| CGIX CANCER GENETICS, INC | S Sale | 2016-11-16 | 2016-11-16 | 3,333 | $1.56 | $5.2K | 14,167 | SEC↗ |
| CGIX CANCER GENETICS, INC | P Buy deriv | 2015-11-12 | 2015-11-16 | 5,000 | — | $0 | 5,000 | SEC↗ |
| CGIX CANCER GENETICS, INC | P Buy | 2015-11-12 | 2015-11-16 | 5,000 | — | $0 | 17,500 | SEC↗ |
| CGIX CANCER GENETICS, INC | P Buy | 2015-03-16 | 2015-03-18 | 1,000 | $6.99 | $7.0K | 12,500 | SEC↗ |
| CGIX CANCER GENETICS, INC | P Buy | 2014-12-12 | 2014-12-15 | 500 | $6.26 | $3.1K | 11,500 | SEC↗ |
| CGIX CANCER GENETICS, INC | A Award deriv | 2014-12-11 | 2014-12-15 | 90,000 | — | $0 | 90,000 | SEC↗ |
| CGIX CANCER GENETICS, INC | A Award deriv | 2014-05-22 | 2014-05-27 | 90,000 | — | $0 | 90,000 | SEC↗ |
| CGIX CANCER GENETICS, INC | A Award | 2014-05-22 | 2014-05-27 | 10,000 | — | $0 | 11,000 | SEC↗ |
| CGIX CANCER GENETICS, INC | P Buy | 2014-05-21 | 2014-05-22 | 1,000 | $10.67 | $10.7K | 1,000 | SEC↗ |